Cite
HARVARD Citation
Ames, P. et al. (2019). Rituximab/Bendamustine treatment of chronic lymphatic leukemia leads to sustained remission of antiphospholipid antibodies. European journal of immunology. 49 (6), pp. 969-970. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ames, P. et al. (2019). Rituximab/Bendamustine treatment of chronic lymphatic leukemia leads to sustained remission of antiphospholipid antibodies. European journal of immunology. 49 (6), pp. 969-970. [Online].